Author:
Hayes R.,Gallo R.,Fuster V.,Chesebro J.
Publisher
Springer Berlin Heidelberg
Reference186 articles.
1. Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI (1985) Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions. Blood 65:32–40
2. Adgey AA (1998) An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Eur Heart J 19 [Suppl D]:D10–D21
3. AIMS Trial Study Group (1988) Effect of intravenous APSAC on mortality after acute myocardial infarction. Preliminary report of a placebo-controlled clinical trial. Lancet 1:545–549
4. Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, McIntire LV (1993) Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 81:1263–1276
5. Ambrose JA (1992) Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different? J Am Coll Cardiol 19:1653–1658